Jim Behling is a notable inventor based in Eagle River, Wisconsin, who has made significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, he has focused on developing innovative solutions for medical challenges.

Latest Patents

Among his latest patents is the invention of L-ornithine phenyl acetate and methods of making the same. This patent discloses various forms of L-ornithine phenyl acetate, including crystalline forms that may be classified as Forms I, II, III, and V, or mixtures thereof. These crystalline forms are designed for treating subjects with liver disorders, such as hepatic encephalopathy. The patent also includes formulations and methods for administering L-ornithine phenyl acetate, showcasing Behling's commitment to addressing critical health issues.

Career Highlights

Jim Behling is currently associated with Ocera Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that can significantly improve patient outcomes.

Collaborations

Throughout his career, Behling has collaborated with talented professionals, including Keith Anderson and Christine Henderson Dougan. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical solutions.

Conclusion

Jim Behling's contributions to the field of pharmaceuticals, particularly through his patents on L-ornithine phenyl acetate, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating liver disorders, demonstrating the impact of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.